evans blue has been researched along with Diabetes Mellitus, Type 1 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chopp, M; Cui, X; Lu, M; Ning, R; Roberts, C; Yan, T; Zacharek, A; Zhang, C | 1 |
1 other study(ies) available for evans blue and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Tissue plasminogen activator treatment of stroke in type-1 diabetes rats.
Topics: Animals; Blood-Brain Barrier; Blotting, Western; Cerebral Hemorrhage; Coloring Agents; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Evans Blue; Fibrinolytic Agents; Immunohistochemistry; Infarction, Middle Cerebral Artery; Male; Matrix Metalloproteinase 9; Rats; Rats, Wistar; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Recovery of Function; Stroke; Tissue Plasminogen Activator; Toll-Like Receptor 4; Treatment Outcome | 2012 |